Deutsch English Français

Contact

EP0662324

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0662324

EP0662324 - Use of beta-adrenergic agonists for treating loss of function of striated muscles [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 16.05.1997 Database last updated on 25.09.2024
Most recent event Tooltip	23.10.2009	Change - representative	published on 25.11.2009 [2009/48]
Applicant(s)	For all designated states The Rowett Research Institute Greenburn Road Bucksburn Aberdeen AB2 9SB Scotland / GB
	[N/P]
Former [1995/28]	For all designated states The Rowett Research Institute Greenburn Road Bucksburn Aberdeen AB2 9SB Scotland / GB
Inventor(s)	01 / Maltin, Charlotte Woodside Cottage, Keith-Hall Estate Aberdeenshire AB51 0LE / GB
	[1995/28]
Representative(s)	Ouzman, Beverley Nicola Claire Murgitroyd & Company Scotland House 165-169 Scotland Street Glasgow G5 8PL / GB
	[N/P]
Former [2009/48]	Ouzman, Beverley Nicola Claire Murgitroyd & Company Scotland House 165-169 Scotland Street Glasgow G5 8PL / GB
Former [1995/28]	Ouzman, Beverley Nicola Claire Murgitroyd and Company, 373 Scotland Street Glasgow G5 8QA / GB
Application number, filing date	95101362.2	12.09.1988
	[1995/28]
Priority number, date	GB19870021602	15.09.1987 Original published format: GB 8721602
	GB19880003619	17.02.1988 Original published format: GB 8803619
	[1995/28]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP0662324
	Date:	12.07.1995
	Language:	EN
	[1995/28]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	15.05.1995
Classification	IPC:	A61K31/135, A61K31/275, A61K31/52	[1995/28]
	CPC:	A61K31/135 (EP); A61K31/275 (EP); A61K31/52 (EP)
Designated contracting states	AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE [1995/28]
Title	German:	Verwendung von beta-adrenergen Agonisten zur Behandlung von Funktionsverlusten der quergestreiften Muskeln	[1995/28]
	English:	Use of beta-adrenergic agonists for treating loss of function of striated muscles	[1995/28]
	French:	Utilisation d'agonistes bêta-adrénergiques pour le traitement des pertes de fonction des muscles striés	[1995/28]
Examination procedure	09.01.1996	Examination requested [1996/11]
	27.06.1996	Despatch of a communication from the examining division (Time limit: M06)
	08.01.1997	Application deemed to be withdrawn, date of legal effect [1997/27]
	05.02.1997	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1997/27]
Parent application(s) Tooltip	EP88308402.2 / EP0308157
Fees paid	Renewal fee
	01.02.1995	Renewal fee patent year 03
	01.02.1995	Renewal fee patent year 04
	01.02.1995	Renewal fee patent year 05
	01.02.1995	Renewal fee patent year 06
	01.02.1995	Renewal fee patent year 07
	23.10.1995	Renewal fee patent year 08
	Penalty fee
	Additional fee for renewal fee
	01.10.1995	08 M06 Fee paid on 23.10.1995
	30.09.1996	09 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XY]EP0026298 (AMERICAN CYANAMID CO [US]) [XY] 1-20 * page 1, lines 15-25 * * page 2, line 24 - page 3, line 2 * * page 7, line 36 - page 8, line 15; example -; claim - *;
		[XY]EP0117647 (LILLY CO ELI [US]) [XY] 1-20 * page 1, line 15 - page 3, line 4 * * page 10, lines 5-18; example -; claim - *;
		[E]WO8908709 (TISDALE MICHAEL JOHN [GB], et al) [E] 1-20 * page 16, lines 25-32 * * page 48, lines 16-32 * * page 49, lines 5-12; claim 16 *;
		[X] - C.A. MALTIN, "The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle", BIOSCI. REP., (198702), vol. 7, no. 2, pages 143 - 149 [X] 1-4,6-11,15-19 * the whole document *
		[X] - N.J. ROTHWELL, "Modification of body composition by clenbuterol in normal and dystrophic (mdx) mice", BIOSCI. REP., (1985), vol. 5, no. 9, pages 755 - 760 [X] 1-4,6-11,15-19 * the whole document *
		[X] - R.J. ZEMAN, "Clenbuterol, a beta2-agonist, retards atrophy in denervated muscles.", AM. J. PHYSIOL., (198701), vol. 252, no. 1PT1, pages E152 - E155 [X] 1-4,6-11,15-19 * the whole document *
		[X] - C.A. MALTIN, "Inhibition and reversal of denervation-induced atrophy by the beta-agonist growth promoter, clenbuterol.", BIOSCI. REP., (1986), vol. 6, no. 9, pages 811 - 818 [X] 1-4,6-11,15-19 * the whole document *
		[X] - C.A. MALTIN, "Clenbuterol, a beta-agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms.", BIOSCI. REP., (198706), vol. 7, no. 6, pages 525 - 532 [X] 1-4,6-11,15-19 * the whole document *
		[X] - P.W. EMERY, "Chronic effects of beta2-adrenergic agonists on body composition and protein synthesis in the rat.", BIOSCI. REP., (1984), vol. 4, no. 1, pages 83 - 91 [X] 1-4,6-11,15-19 * the whole document *
		[X] - D.H. BERMANN, "Effect of cimaterol and fishmeal on body composition and skeletal muscle growth in lambs.", CHEMICAL ABSTRACTS, (1987), vol. 106, no. 7, Database accession no. 49103g [X] 1-3,5-11,16-20 * abstract *
		[ ] - Proc. Cornell Nutr. Conf. Feed Manuf., 1986, pp. 29-38
		[X] - C.A. MALTIN, "Propranolol apparently separates the physical and compositional characteristics of muscle growth inducced by clenbuterol.", BIOSCI. REP., (198701), vol. 7, no. 1, pages 51 - 57 [X] 1-4,6-11,15-19 * the whole document *
		[PX] - P.J. REEDS, "The effect of beta-agonists and antagonists on muscle growth and body composition of young rat (rattus sp.)", COMP. BIOCHEM. PHYSIOL., (1988), vol. 89C, no. 2, pages 337 - 341 [PX] 1-20 * the whole document *
		[A] - R.W. KIERSTEAD, "Beta1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.", J. MED. CHEM., (1983), vol. 26, no. 11, doi:doi:10.1021/jm00365a004, pages 1561 - 1569, XP002922416 [A] 12-14 * the whole document * DOI: http://dx.doi.org/10.1021/jm00365a004
		[T] - C.A. MALTIN, "The effect of clenbuterol administration in utero and throughout lactation on pre- and post-natal muscle development in the rat.", GROWTH DEV. AGING, (1990), vol. 54, no. 4, pages 143 - 150 [T] 1-4,6-11,15-19 * the whole document *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p